Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
Go back to Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution| AZTECA ACQUISITION CORP (NASDAQ: AZTA) | Delayed: 22.27 -1.04 (4.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.31 | 52 Week High | $10.45 | |||
| Open | $23.33 | 52 Week Low | $9.73 | |||
| Day High | $23.61 | P/E | 71.84 | |||
| Day Low | $22.19 | EPS | $0.31 | |||
| Volume | 590,848 | |||||
